Global Intra-articular Drug Injection Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Intra-articular Drug Injection Market Research Report 2024
Intra-articular therapy (intra-articular injection therapy; IAT) is used primarily to treat synovitis, effusion, and pain relief in adults
According to QYResearch’s new survey, global Intra-articular Drug Injection market is projected to reach US$ 8465 million in 2034, increasing from US$ 4790 million in 2022, with the CAGR of 8.6% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intra-articular Drug Injection market research.
Key manufacturers engaged in the Intra-articular Drug Injection industry include Sanofi, SEIKAGAKU CORPORATION, Bioventus, Anika Therapeutics,Inc., Pacira BioSciences,Inc., Dr.Reddy's Laboratories Ltd., Zimmer Biomet, Teva Pharmaceutical lndustries Ltd. and Ferring B.V., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Intra-articular Drug Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Intra-articular Drug Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Intra-articular Drug Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Sanofi
SEIKAGAKU CORPORATION
Bioventus
Anika Therapeutics,Inc.
Pacira BioSciences,Inc.
Dr.Reddy's Laboratories Ltd.
Zimmer Biomet
Teva Pharmaceutical lndustries Ltd.
Ferring B.V.
Segment by Type
Glucocorticoids
Local Anesthetic
Hyaluronic Acid
Radiopharmaceuticals
Others
Hospital
Clinic
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Intra-articular Drug Injection report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to QYResearch’s new survey, global Intra-articular Drug Injection market is projected to reach US$ 8465 million in 2034, increasing from US$ 4790 million in 2022, with the CAGR of 8.6% during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intra-articular Drug Injection market research.
Key manufacturers engaged in the Intra-articular Drug Injection industry include Sanofi, SEIKAGAKU CORPORATION, Bioventus, Anika Therapeutics,Inc., Pacira BioSciences,Inc., Dr.Reddy's Laboratories Ltd., Zimmer Biomet, Teva Pharmaceutical lndustries Ltd. and Ferring B.V., etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Intra-articular Drug Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Intra-articular Drug Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Intra-articular Drug Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sanofi
SEIKAGAKU CORPORATION
Bioventus
Anika Therapeutics,Inc.
Pacira BioSciences,Inc.
Dr.Reddy's Laboratories Ltd.
Zimmer Biomet
Teva Pharmaceutical lndustries Ltd.
Ferring B.V.
Segment by Type
Glucocorticoids
Local Anesthetic
Hyaluronic Acid
Radiopharmaceuticals
Others
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Intra-articular Drug Injection report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source